Along with your above comments, I think the point that the late trial date wasn't at Momenta's request is bullish. As Rick Shea mentioned in a previous presentation, had the judge thought Teva was close to obtaining tL approval he/she would have scheduled a much earlier trial date.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.